Dietary intake of folate, but not vitamin B2 or B12, is associated with increased bone mineral density 5 years after the menopause: Results from a 10-year follow-up study in early postmenopausal women

Calcified Tissue International

Volumn 82, Issue 1, 2008, Pages 1-11

  Rejnmark, L ^a   Vestergaard, P ^a   Hermann, A P ^b   Brot, C ^c   Eiken, P ^d   Mosekilde, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d HILLERØD HOSPITAL   (Denmark)

Author keywords

Bone mineral density; Cobalamin; Folate; Fracture; Osteoporosis; Riboflavin; Vitamin B12; Vitamin B6; Women

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; RIBOFLAVIN;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; DIETARY INTAKE; FEMALE; FEMUR NECK; FOLLOW UP; FRACTURE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADULT; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; DIETARY SUPPLEMENTS; FEMALE; FEMUR NECK; FOLIC ACID; FOLLOW-UP STUDIES; FOOD, FORMULATED; FRACTURES, BONE; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; NUTRITIONAL REQUIREMENTS; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; RIBOFLAVIN; TIME; TIME FACTORS; VITAMIN B 12;

EID: 39149099782     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-007-9087-0     Document Type: Article

References (39)

1. 12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab 89:1217-1221
2. 12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J Nutr 133:801-807
3. 12 is associated with lower BMD: the Framingham Osteoporosis Study. J Bone Miner Res 20:152-158
4. Morris MS, Jacques PF, Selhub J (2005) Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37:234-242
5. Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR (2004) Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 35:760-765
6. 12 to bone mineral density of postmenopausal women. Bone 33:956-959
7. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK, Tell GS (2006) Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 166:88-94
8. 6 with bone mineral density in postmenopausal British women. Bone 40:730-736
9. Ravaglia G, Forti P, Maioli F, Servadei L, Martelli M, Brunetti N, Bastagli L, Cucinotta D, Mariani E (2005) Folate, but not homocysteine, predicts the risk of fracture in elderly persons. J Gerontol A Biol Sci Med Sci 60:1458-1462
10. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293:1082-1088
11. Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM (2004) Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 79:155-165
12. van Meurs JBJ, Dhonukshe-Rutten RAM, Pluijm SMF, van der Klift M, de Jonge R, Lindemans J, de Groot LCPG, Hofman A, Witteman JCM, van Leeuwen JPTM, Breteler MMB, Lips P, Pols HAP, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033-2041
13. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042-2049
14. McLean RR, Karasik D, Selhub J, Tucker KL, Ordovas JM, Russo GT, Cupples LA, Jacques PF, Kiel DP (2004) Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 19:410-418
15. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L (2003) A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish Osteoporosis Prevention Study. J Bone Miner Res 18:723-729
16. Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, Shiraki M, Yazaki Y, Ouchi Y (2000) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66:190-194
17. Jorgensen HL, Madsen JS, Madsen B, Saleh MM, Abrahamsen B, Fenger M, Lauritzen JB (2002) Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women. Calcif Tissue Int 71:386-392
18. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L (2005) Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish Osteoporosis Prevention Study. Bone 36:577-583
19. Jadad AR (1998) Randomised controlled trials. A useŕs guide. BMJ Books, London
20. Mosekilde L, Hermann AP, Beck NH, Charles P, Nielsen SP, Sorensen OH (1999) The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 31:207-219
21. Vestergaard P, Hermann AP, Gram J, Jensen LB, Kolthoff N, Abrahamsen B, Brot C, Eiken P (1997) Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas 28:137-145
22. Moller A (1989) Food composition tables. Publication SC3. Danish National Food Agency, Copenhagen
23. Bailey LB (1998) Dietary reference intakes for folate: the debut of dietary folate equivalents. Nutr Rev 56:294-299
24. Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H (1995) Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone 16:385-390
25. World Health Organization, Food, Agriculture Organization of the United Nations (2002) Human vitamin and mineral requirements: report of a joint FAO/WHO expert consultation, Bangkok, Thailand. World Health Organization, Food and Agriculture Organization of the United Nations, Rome
26. Browner WS, Malinow MR (1991) Homocyst(e)inaemia and bone density in elderly women. Lancet 338:1470
27. Jackson SH (1973) The reaction of homocysteine with aldehyde: an explanation of the collagen defects in homocystinuria. Clin Chim Acta 45:215-217
28. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL (1999) Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 131:331-339
29. McNulty H, McKinley MC, Wilson B, McPartlin J, Strain JJ, Weir DG, Scott JM (2002) Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am J Clin Nutr 76:436-441
30. Macdonald HM, McGuigan FE, Fraser WD, New SA, Ralston SH, Reid DM (2004) Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 35:957-964
31. Eastell R, Vieira NE, Yergey AL, Wahner HW, Silverstein MN, Kumar R, Riggs BL (1992) Pernicious anaemia as a risk factor for osteoporosis. Clin Sci (Lond) 82:681-685
32. Goerss JB, Kim CH, Atkinson EJ, Eastell R, O'Fallon WM, Melton LJ III (1992) Risk of fractures in patients with pernicious anemia. J Bone Miner Res 7:573-579
33. Carmel R, Lau KH, Baylink DJ, Saxena S, Singer FR (1988) Cobalamin and osteoblast-specific proteins. N Engl J Med 319:70-75
34. 12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 45:1443-1446
35. Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG, Scott JM (1997) Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM 90:519-524
36. Yang TL, Hung J, Caudill MA, Urrutia TF, Alamilla A, Perry CA, Li R, Hata H, Cogger EA (2005) A long-term controlled folate feeding study in young women supports the validity of the 1.7 multiplier in the dietary folate equivalency equation. J Nutr 135:1139-1145
37. 14C-cobalamin. Proc Natl Acad Sci USA 103:5694-5699
38. Howard JM, Azen C, Jacobsen DW, Green R, Carmel R (1998) Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels. Eur J Clin Nutr 52:582-587
39. 12 concentrations relate to intake source in the Framingham Offspring Study. Am J Clin Nutr 71:514-522